Torii Eager to Carve Out New Market with Japan’s 1st Sublingual Allergen Immunotherapy

November 25, 2014
Torii Pharmaceutical aims to popularize allergen immunotherapy in Japan with the launch of its Cedartolen Sublingual Drop (Japanese cedar pollen extract), an allergen immunotherapy for Japanese cedar pollinosis. The company is also developing a sublingual tablet formulation of Cedartolen as...read more